---
document_datetime: 2025-12-29 14:34:51
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-ratiopharm-gmbh.html
document_name: clopidogrel-ratiopharm-gmbh.html
version: success
processing_time: 0.125323
conversion_datetime: 2025-12-31 01:37:04.893849
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel ratiopharm GmbH

[RSS](/en/individual-human-medicine.xml/65852)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Clopidogrel Ratiopharm GmbH](#more-information-on-clopidogrel-ratiopharm-gmbh-1113)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 January 2020, the European Commission withdrew the marketing authorisation for Clopidogrel ratiopharm GmbH (clopidogrel) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Archie Samuel s.r.o., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Clopidogrel ratiopharm GmbH was granted marketing authorisation in the EU on 28 July 2009 for prevention of atherothrombotic events. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2014.

Clopidogrel ratiopharm GmbH is a generic medicine of Plavix. There are other generic medicinal products of Plavix authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Clopidogrel ratiopharm GmbH is updated to indicate that the marketing authorisation is no longer valid.

Clopidogrel ratiopharm GmbH : EPAR - Summary for the public

English (EN) (619.48 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 28/02/2013

[View](/en/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-7)

български (BG) (748.14 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/bg/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_bg.pdf)

español (ES) (699.21 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/es/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_es.pdf)

čeština (CS) (774.98 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/cs/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_cs.pdf)

dansk (DA) (698.71 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/da/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_da.pdf)

Deutsch (DE) (699.89 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/de/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_de.pdf)

eesti keel (ET) (698.1 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/et/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_et.pdf)

ελληνικά (EL) (816.71 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/el/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_el.pdf)

français (FR) (697.65 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/fr/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_fr.pdf)

italiano (IT) (736.11 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/it/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_it.pdf)

latviešu valoda (LV) (717.15 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/lv/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (696.28 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/lt/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_lt.pdf)

magyar (HU) (748.24 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/hu/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_hu.pdf)

Malti (MT) (773.38 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/mt/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_mt.pdf)

Nederlands (NL) (699.22 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/nl/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_nl.pdf)

polski (PL) (774.48 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/pl/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_pl.pdf)

português (PT) (639.16 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/pt/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_pt.pdf)

română (RO) (664.03 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/ro/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_ro.pdf)

slovenčina (SK) (771.09 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/sk/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_sk.pdf)

slovenščina (SL) (766.49 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/sl/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_sl.pdf)

Suomi (FI) (692.08 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/fi/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_fi.pdf)

svenska (SV) (698.39 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2013

[View](/sv/documents/overview/clopidogrel-ratiopharm-gmbh-epar-summary-public_sv.pdf)

## Product information

Clopidogrel ratiopharm GmbH : EPAR - Product Information

English (EN) (900.55 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 02/10/2019

[View](/en/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-57)

български (BG) (2.02 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/bg/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_bg.pdf)

español (ES) (1.05 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/es/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_es.pdf)

čeština (CS) (1.71 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/cs/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_cs.pdf)

dansk (DA) (1.05 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/da/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/de/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_de.pdf)

eesti keel (ET) (1.07 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/et/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_et.pdf)

ελληνικά (EL) (2.07 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/el/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_el.pdf)

français (FR) (1.12 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/fr/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_fr.pdf)

hrvatski (HR) (1.14 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/hr/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_hr.pdf)

íslenska (IS) (1.04 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/is/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_is.pdf)

italiano (IT) (1.06 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/it/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_it.pdf)

latviešu valoda (LV) (1.71 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/lv/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.15 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/lt/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_lt.pdf)

magyar (HU) (1.81 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/hu/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_hu.pdf)

Malti (MT) (1.93 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/mt/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_mt.pdf)

Nederlands (NL) (1.08 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/nl/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_nl.pdf)

norsk (NO) (1.03 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/no/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_no.pdf)

polski (PL) (960.36 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/pl/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_pl.pdf)

português (PT) (1.05 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/pt/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_pt.pdf)

română (RO) (1.2 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/ro/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_ro.pdf)

slovenčina (SK) (1.68 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/sk/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_sk.pdf)

slovenščina (SL) (1.64 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/sl/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_sl.pdf)

Suomi (FI) (886.54 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/fi/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_fi.pdf)

svenska (SV) (1.1 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

02/10/2019

[View](/sv/documents/product-information/clopidogrel-ratiopharm-gmbh-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0036 22/08/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel ratiopharm GmbH : EPAR - All Authorised presentations

English (EN) (574.5 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 31/03/2011

[View](/en/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-931)

български (BG) (1.2 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/bg/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_bg.pdf)

español (ES) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/es/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_es.pdf)

čeština (CS) (1.19 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/cs/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/da/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/de/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/et/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (1.2 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/el/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_el.pdf)

français (FR) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/fr/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/it/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (1.2 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/lv/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (1.18 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/lt/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (1.2 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/hu/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (1.19 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/mt/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/nl/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_nl.pdf)

polski (PL) (1.16 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/pl/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_pl.pdf)

português (PT) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/pt/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_pt.pdf)

română (RO) (1.18 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/ro/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (1.16 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/sk/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (1.13 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/sl/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/fi/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (1.12 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

31/03/2011

[View](/sv/documents/all-authorised-presentations/clopidogrel-ratiopharm-gmbh-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel ratiopharm GmbH Active substance clopidogrel International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Acute Coronary Syndrome
- Myocardial Infarction
- Stroke

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease;
- patients suffering from acute coronary syndrome:
    - non-ST-segment-elevation acute coronary syndrome (unstable angina or non-Q wave-myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA);
    - ST-segment-elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

## Authorisation details

EMA product number EMEA/H/C/001165

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Archie Samiel s.r.o.

Slunná 16

Marketing authorisation issued 28/07/2009 Withdrawal of marketing authorisation 13/01/2020 Revision 12

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel ratiopharm GmbH : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (700.68 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 02/10/2019

[View](/en/documents/procedural-steps-after/clopidogrel-ratiopharm-gmbh-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Clopidogrel ratiopharm GmbH-H-C-1165-A20-09 : EPAR - Assessment Report - Article 20

Adopted

English (EN) (720.38 KB - PDF)

**First published:** 31/03/2011

**Last updated:** 31/03/2011

[View](/en/documents/variation-report/clopidogrel-ratiopharm-gmbh-h-c-1165-a20-09-epar-assessment-report-article-20_en.pdf)

## Initial marketing authorisation documents

Clopidogrel ratiopharm GmbH : EPAR - Public assessment report

English (EN) (833.13 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 08/09/2009

[View](/en/documents/assessment-report/clopidogrel-ratiopharm-gmbh-epar-public-assessment-report_en.pdf)

Summary of positive opinion for Clopidogrel Ratiopharm GmbH

English (EN) (601.17 KB - PDF)

**First published:** 29/05/2009

**Last updated:** 29/05/2009

[View](/en/documents/smop-initial/summary-positive-opinion-clopidogrel-ratiopharm-gmbh_en.pdf)

#### More information on Clopidogrel Ratiopharm GmbH

Public statement on Clopidogrel ratiopharm GmbH: Withdrawal of the marketing authorisation in the European Union

Reference Number: EMA/CHMP/10194/2021

English (EN) (129.56 KB - PDF)

**First published:** 25/01/2021

[View](/en/documents/public-statement/public-statement-clopidogrel-ratiopharm-gmbh-withdrawal-marketing-authorisation-european-union_en.pdf)

Questions and answers on the precautionary recall of batches of clopidogrel-containing medicines

Reference Number: EMA/179698/2010

English (EN) (58.98 KB - PDF)

**First published:** 25/03/2010

**Last updated:** 25/03/2010

[View](/en/documents/medicine-qa/questions-and-answers-precautionary-recall-batches-clopidogrel-containing-medicines_en.pdf)

Questions and answers on generic medicines

Reference Number: EMA/393905/2006 Rev. 2

English (EN) (66.45 KB - PDF)

**First published:** 09/07/2007

**Last updated:** 07/12/2012

[View](/en/documents/other/questions-and-answers-generic-medicines_en.pdf)

[Other languages (22)](#file-language-dropdown-573)

български (BG) (93.16 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/bg/documents/other/questions-and-answers-generic-medicines_bg.pdf)

español (ES) (68.3 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/es/documents/other/questions-and-answers-generic-medicines_es.pdf)

čeština (CS) (87.71 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/cs/documents/other/questions-and-answers-generic-medicines_cs.pdf)

dansk (DA) (66.79 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/da/documents/other/questions-and-answers-generic-medicines_da.pdf)

Deutsch (DE) (67.55 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/de/documents/other/questions-and-answers-generic-medicines_de.pdf)

eesti keel (ET) (65.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/et/documents/other/questions-and-answers-generic-medicines_et.pdf)

ελληνικά (EL) (91.29 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/el/documents/other/questions-and-answers-generic-medicines_el.pdf)

français (FR) (68.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fr/documents/other/questions-and-answers-generic-medicines_fr.pdf)

hrvatski (HR) (87.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hr/documents/other/questions-and-answers-generic-medicines_hr.pdf)

italiano (IT) (67.62 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/it/documents/other/questions-and-answers-generic-medicines_it.pdf)

latviešu valoda (LV) (111.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lv/documents/other/questions-and-answers-generic-medicines_lv.pdf)

lietuvių kalba (LT) (86.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lt/documents/other/questions-and-answers-generic-medicines_lt.pdf)

magyar (HU) (85.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hu/documents/other/questions-and-answers-generic-medicines_hu.pdf)

Malti (MT) (89.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/mt/documents/other/questions-and-answers-generic-medicines_mt.pdf)

Nederlands (NL) (66.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/nl/documents/other/questions-and-answers-generic-medicines_nl.pdf)

polski (PL) (88.51 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pl/documents/other/questions-and-answers-generic-medicines_pl.pdf)

português (PT) (68.32 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pt/documents/other/questions-and-answers-generic-medicines_pt.pdf)

română (RO) (86.9 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/ro/documents/other/questions-and-answers-generic-medicines_ro.pdf)

slovenčina (SK) (87.73 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sk/documents/other/questions-and-answers-generic-medicines_sk.pdf)

slovenščina (SL) (84.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sl/documents/other/questions-and-answers-generic-medicines_sl.pdf)

Suomi (FI) (66.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fi/documents/other/questions-and-answers-generic-medicines_fi.pdf)

svenska (SV) (67.11 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sv/documents/other/questions-and-answers-generic-medicines_sv.pdf)

**This page was last updated on** 25/01/2021

## Share this page

[Back to top](#main-content)